Medibio: Raises $3.5M via placement and SPP

  • Health technology company Medibio (MEB) plans to raise up to $3.5 million through a capital raise and share purchase plan
  • The company has received commitments for a $3 million placement of around 333.3 million new fully paid ordinary shares
  • Medibio will offer investors one free attaching option for every four new shares issued at 1.5 cents per option
  • Medibio will also conduct a $500,000 share purchase plan, which expected to fully underwritten
  • Proceeds will fund a depressive burden trial, MEBsleep and ilumen product commercialisation activities and consumer app development
  • Medibio is up 11.11 per cent and trading at 1 cent per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

AI Compliance in Fintech: Balancing Innovation with Compliance

AI compliance in fintech is becoming a hot topic as more companies adopt AI technologies. With innovation comes...

Understanding the GENIUS Act Stablecoin Regulation

The GENIUS Act stablecoin is shaking up the world of digital currency. With the FDIC now implementing this...

Understanding the Rise of Banking Licenses in Fintech

Banking licenses in fintech are becoming a big deal. They're helping fintech companies expand their services and build...

Top Fintech Trends 2026: What to Watch For

Fintech trends 2026 are shaking up the financial world with AI integration and new regulations. If you're in...